CLINICAL_TRIALS
trial_result
· 2025-08-07
Clinical Trial Update: A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact [Phase 2]
Summary
Phase 2 dose-ranging trial of AeroFact in premature infants with respiratory distress syndrome has been completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aerogen Pharma Limited | Conditions: Respiratory Distress Syndrome in Premature Infant | Phase 2 | Status: COMPLETED | Results posted: 2025-08-07